Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 35Neoplasms 23Motor Activity 11Stomach Neoplasms 7Pain, Postoperative 7Lung Neoplasms 7Fatigue 7Colorectal Neoplasms 7Pain 5Anxiety Disorders 5Polycystic Ovary Syndrome 4Depression 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Thyroid Neoplasms 3Stomatitis 3Sleep Initiation and Maintenance Disorders 3Rectal Neoplasms 3Prostatic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Malnutrition 3Liver Neoplasms 3Leukemia, Myeloid, Acute 3Colonic Neoplasms 3Agnosia 3Vomiting 2Urinary Incontinence 2Squamous Cell Carcinoma of Head and Neck 2Parasomnias 2Ovarian Neoplasms 2

Interventions

3-Iodobenzylguanidine 8anlotinib 4Temozolomide 4lutetium Lu 177 dotatate 3Phenoxybenzamine 3Everolimus 3pegfilgrastim 2cabozantinib 2Granulocyte Colony-Stimulating Factor 2Doxazosin 2Dexmedetomidine 2Capecitabine 2Adrenalectomy 23-fluorobenzylguanidine 2177Lu-octreotide, DOTA(0)-Tyr(3)- 2veliparib 1vatalanib 1vandetanib 1temsirolimus 1pentetreotide 1penpulimab 1pembrolizumab 1olaparib 1lenvatinib 1lanreotide 1gallium Ga 68 dotatate 1fluorodopa F 18 1fludarabine phosphate 1belzutifan 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pheochromocytoma × Control Groups × Clear all
NCT04320589 2021-09-01

the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma

National Cancer Institute, Egypt

Phase 2 Completed
30 enrolled
Endocrine

Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡